At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,028 enrolled
Drug / intervention
type of decision aidbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of a Plain Language Prostate Cancer Decision Aid on Decision Making
In Brief
A clinical study evaluating type of decision aid for Prostate Cancer. Completed, enrolled 1,028 participants across 4 sites.
Detailed Summary
The purpose of this study is to test different methods for communicating information about prostate cancer treatment to men. The investigators are studying how best to present information so men can make informed decisions about what prostate cancer treatment to undergo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2007
Enrollment StartAug 2008
Primary CompletionSep 2012
TodayJul 2026
First PostedFeb 8, 2007
Enrollment StartAug 1, 2008
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 19.4 years ago
Interventions
type of decision aidbehavioral
We will be comparing two decision aids (MCC vs. NCCN) in terms of their impact on decision making and patient-physician communication.